An AstraZeneca immunotherapy improved survival rates in patients with bladder cancer, results that could reshape treatment of ...

For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place ...

The US Food and Drug Administration (FDA) has approved atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza, Genentech, Inc ...

The efficacy of rucaparib plus nivolumab was compared with rucaparib monotherapy as maintenance treatment for ovarian cancer.

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Circle Pharma, Inc., a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable ...

AZ and Genentech have a major interest in ... Both companies also have late-stage PD-L1 immunotherapy drugs in development for lung cancer, with Roche's MPDL3280A looking particularly promising ...

Warner Biddle and Christi Shaw, two prominent former executives at Gilead’s CAR-T division, will try to turn around an ...

Using Herceptin as an example, Andre Ilbawi detailed the challenges low- and medium-income countries face in accessing essential therapies.

Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape ...

The result is a welcome endorsement of patritumab derxutecan's potential after the HER3-directed antibody-drug conjugate (ADC ...

Pharmaceutical stocks largely shook off the brunt of negotiated drug prices. But that doesn't mean they'll be spared election noise.